Express Scripts Holding Company (ESRX) VP Christine Houston Sells 10,104 Shares
Express Scripts Holding Company (NASDAQ:ESRX) VP Christine Houston sold 10,104 shares of the stock in a transaction on Friday, December 15th. The shares were sold at an average price of $70.08, for a total value of $708,088.32. Following the completion of the sale, the vice president now owns 87,400 shares of the company’s stock, valued at approximately $6,124,992. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Express Scripts Holding Company (ESRX) traded up $1.83 during trading hours on Monday, hitting $73.38. The company had a trading volume of 6,902,488 shares, compared to its average volume of 4,151,759. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. Express Scripts Holding Company has a twelve month low of $55.80 and a twelve month high of $73.46. The stock has a market capitalization of $40,523.99, a price-to-earnings ratio of 10.46, a price-to-earnings-growth ratio of 1.06 and a beta of 0.88.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.90. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. The business had revenue of $24.68 billion during the quarter, compared to analyst estimates of $25.68 billion. During the same period last year, the company earned $1.74 earnings per share. Express Scripts’s quarterly revenue was down 2.9% compared to the same quarter last year. sell-side analysts anticipate that Express Scripts Holding Company will post 7.02 earnings per share for the current fiscal year.
ESRX has been the subject of a number of research analyst reports. Robert W. Baird increased their target price on Express Scripts from $57.00 to $59.00 and gave the company a “neutral” rating in a report on Wednesday, October 25th. Jefferies Group set a $72.00 target price on Express Scripts and gave the company a “buy” rating in a report on Tuesday, August 29th. Zacks Investment Research lowered Express Scripts from a “buy” rating to a “sell” rating in a report on Tuesday, October 24th. Royal Bank of Canada set a $66.00 target price on Express Scripts and gave the company a “hold” rating in a report on Wednesday, October 25th. Finally, UBS lowered Express Scripts from a “market perform” rating to an “underperform” rating in a report on Monday, October 9th. Five investment analysts have rated the stock with a sell rating, ten have given a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. Express Scripts presently has a consensus rating of “Hold” and an average target price of $74.40.
COPYRIGHT VIOLATION NOTICE: This report was published by Watch List News and is the sole property of of Watch List News. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright legislation. The legal version of this report can be read at https://www.watchlistnews.com/express-scripts-holding-company-esrx-vp-christine-houston-sells-10104-shares/1771804.html.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.